Taken together, our results reveal that both alisertib and barasertib lead to cell death, entry into senescence and the induction of polyploidy through one or several cycles of endoreduplication in all MM cell lines, even when cyclin B1 levels remain elevated. Here, CCNB1 is linked to Miyoshi myopathy.